Skip to main content
SkinCited

Vitamin D pour Vitiligo

D Recherche Seules des recherches préliminaires existent (études en laboratoire, rapports de cas).

Research suggests vitamin D deficiency is common in vitiligo patients. Supplementation may support melanocyte function, but clinical evidence for repigmentation is limited.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'skincited.com'; const params = 'ingredient\u003Dvitamin\u002Dd\u0026condition\u003Dvitiligo'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

D

En conclusion

Research suggests vitamin D deficiency is common in vitiligo patients. Supplementation may support melanocyte function, but clinical evidence for repigmentation is limited.

Key Study Findings

retrospective observational with Mendelian randomization
Association of vitamin D with risk of warts: A retrospective and Mendelian randomization study.
Dose: None vs: Placebo Effet: OR 1.86 (95% CI 1.19-2.92) 0.007
Observational Study n=573
Vitiligo: Clinical and Laboratory Characteristics in 573 Saudi Patients.
Dose: None vs: None Outcome: Vitiligo prevalence and clinical characteristics Effet: None None

Population: Saudi patients with vitiligo (573)

Meta-Analysis n=680823
Comorbid Conditions Associated with Alopecia Areata: A Systematic Review and Meta-analysis.
Dose: None vs: Placebo Effet: Vitamin D deficiency OR 10.13 (95% CI 4.24-24.20) None
Observational Study
Effects of age and sex on the comorbidities of alopecia areata: A cross-sectional hospital-based study.
Dose: 36% vs: None Outcome: hair regrowth Effet: None p < 0.05

Population: Aa referred to our hospitals between 2018 and 2021

Other n=38 36 weeks
Paediatric lichen sclerosus et atrophicus: A retrospective analysis of 38 paediatric patients.
Dose: 92.1% vs: None Outcome: None Effet: None None

Population: lsa by a paediatric dermatologist

Key Statistics

4

Études

300

Participants

Positive

D

Note

Referenced Papers

Journal of the … 2020 57 citations
American journal of … 2018 138 citations
Postepy dermatologii i … 2016 59 citations
The British journal … 2014 74 citations
Journal of cutaneous … 2014 35 citations
Pediatric clinics of … 2014 25 citations

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Posologies couramment utilisées

general:
600-800 IU/day (RDA)
skinhealth:
1,000-4,000 IU/day (targeting 30-50 ng/mL serum 25(OH)D)

Limite supérieure : 4,000 IU/day (IOM); many experts consider up to 10,000 IU/day safe

Posologies étudiées dans la recherche

Posologie Durée Effet N
None -- Mixed --
None -- Neutral 573
None -- Positive 680823
None -- Negative 90
36% -- Mixed --
92.1% 36 weeks Positive 38
None -- Positive 8314220
None -- Negative --

Moment optimal de prise : With meals containing fat for better absorption

Safety & Side Effects

Effets indésirables signalés

  • Generally well-tolerated at recommended doses
  • Hypercalcemia at very high doses (nausea, vomiting, weakness)
  • Kidney stones (rare, at excessive doses)

Interactions connues

  • Thiazide diuretics (may increase calcium levels)
  • Corticosteroids (may reduce vitamin D absorption)
  • Orlistat and cholestyramine (reduce absorption of fat-soluble vitamins)
  • Calcipotriene (additive vitamin D effect)

Apport maximal tolérable : 4,000 IU/day (IOM); many experts consider up to 10,000 IU/day safe

Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.

Frequently Asked Questions

Does Vitamin D help with Vitiligo?
Based on 4 studies with 300 participants, there is preliminary evidence that needs more research that Vitamin D may support Vitiligo management. Our evidence grade is D (Very Early Research).
How much Vitamin D should I take for Vitiligo?
Studies have used various dosages. A commonly studied range is 600-800 IU/day (RDA). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamin D?
Reported side effects may include Generally well-tolerated at recommended doses, Hypercalcemia at very high doses (nausea, vomiting, weakness), Kidney stones (rare, at excessive doses). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamin D and Vitiligo?
We rate the evidence as Grade D (Very Early Research). This rating is based on 4 peer-reviewed studies with 300 total participants. The overall direction of effect is positive.

Vitamin D pour d'autres pathologies

References

  1. [1] Yuting Cao et al.. Skin Res Technol. 2024. Association of vitamin D with risk of warts: A retrospective and Mendelian randomization study. doi:10.1111/srt.13911 PubMed
  2. [2] Mohammed Ibrahim AlJasser. Clin Cosmet Investig Dermatol. 2024. Vitiligo: Clinical and Laboratory Characteristics in 573 Saudi Patients. doi:10.2147/CCID.S499794 PubMed
  3. [3] Sophia Ly et al.. Am J Clin Dermatol. 2023. Comorbid Conditions Associated with Alopecia Areata: A Systematic Review and Meta-analysis. doi:10.1007/s40257-023-00805-4 PubMed
  4. [4] Elham Hamidpour et al.. Health Sci Rep. 2023. Effects of age and sex on the comorbidities of alopecia areata: A cross-sectional hospital-based study. doi:10.1002/hsr2.1444 PubMed
  5. [5] N M Dawoud et al.. J Cosmet Dermatol. 2023. Serum brain-derived neurotrophic factor and vitamin D: Two concordant players controlling depression among alopecia areata and vitiligo patients: A case-control … doi:10.1111/jocd.15725 PubMed
  6. [6] Basak Yalici-Armagan et al.. Int J Clin Pract. 2021. Paediatric lichen sclerosus et atrophicus: A retrospective analysis of 38 paediatric patients. doi:10.1111/ijcp.14661 PubMed
  7. [7] R Z Conic et al.. J Eur Acad Dermatol Venereol. 2020. Comorbidities in pediatric alopecia areata. doi:10.1111/jdv.16727 PubMed
  8. [8] Elio Kechichian et al.. Am J Clin Dermatol. 2018. Vitamin D and the Skin: An Update for Dermatologists. doi:10.1007/s40257-017-0323-8 PubMed
  9. [9] Ebru Karagün et al.. Postepy Dermatol Alergol. 2016. The role of serum vitamin D levels in vitiligo. doi:10.5114/pdia.2016.59507 PubMed
  10. [10] A Aksu Cerman et al.. Br J Dermatol. 2014. Vitamin D deficiency in alopecia areata. doi:10.1111/bjd.12980 PubMed
  11. [11] Heidi Wat et al.. J Cutan Med Surg. 2014. Off-label uses of topical vitamin D in dermatology: a systematic review. doi:10.2310/7750.2013.13109 PubMed
  12. [12] Nanette B Silverberg. Pediatr Clin North Am. 2014. Pediatric vitiligo. doi:10.1016/j.pcl.2013.11.008 PubMed
  13. [13] Michael P Pender. Autoimmune Dis. 2012. CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis. doi:10.1155/2012/189096 PubMed

Avertissement FDA: Ces déclarations n'ont pas été évaluées par la Food and Drug Administration. Les produits et informations sur ce site ne sont pas destinés à diagnostiquer, traiter, guérir ou prévenir quelque maladie que ce soit. Les notes de preuve présentées sont basées sur notre analyse de la recherche publiée et évaluée par des pairs et ne constituent pas un avis médical. Consultez toujours votre professionnel de santé avant de commencer tout régime de compléments alimentaires.